NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the Fire Department of New York (FDNY), is expanding its fleet of Mobile Stroke Treatment Units (MSTU) to Queens and Brooklyn. Thanks to a generous donation by the W.P. Carey Foundation, this makes NewYork-Presbyterian the first health system in the country to operate three of these advanced units.
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people considered at low to intermediate risk for cardiovascular disease, according to a study appearing online in the journal Radiology. Almost half of all study participants had at least one narrowed artery.
A new report from the U.S. Food and Drug Administration (FDA) discusses the continued quality, safety and effectiveness of servicing of medical devices by original equipment manufacturers (OEMs) and third-party entities.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 7, 2018 โ Results from an international clinical trial show that combining clopidogrel and aspirin following a ...
June 7, 2018 โ The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used ...
Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate ...
SPONSORED CONTENT โ Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 6, 2018 โ Maquet Datascope Corp. said it is recalling the CardioSave Hybrid Intra-aortic Balloon Pump (IABP) due to ...
June 6, 2018 โ Here is a checklist of dose-sparing practices for angiographic X-ray imaging used in the cath lab. This ...
June 5, 2018 โ The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 5, 2018 โ Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in ...
June 5, 2018 โ The future of cardiovascular care will be transformed by advances in artificial intelligence, digital ...
June 4, 2018 โ The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A new consensus document on how to mitigate radiation exposure in cardiac imaging for both patients and staff was issued ...
June 1, 2018 โ Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with ...
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical image analyzers, or computer-aided detection (CAD) devices, from class III to class II devices. This includes CAD devices for mammography breast cancer, ultrasound breast lesions and radiograph lung nodules.
June 11, 2018
